Last reviewed · How we verify
NCT05442229
A Cross-sectional Study to Evaluate Speech and Language Development in Chinese Children Aged 2-6 Years
trial testing establish a new Chinese children's speech and language norm in Mental Retardation in 5,744 participants. Status unknown.
28 February 2023
Quick facts
| Lead sponsor | Tongji Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 5,744 |
| Start date | 1 July 2022 |
| Primary completion | 28 February 2023 |
| Estimated completion | 28 February 2023 |
Drugs / interventions tested
- establish a new Chinese children's speech and language norm
Conditions studied
- Mental Retardation — all drugs for Mental Retardation →
- Autism Spectrum Disorder — all drugs for Autism Spectrum Disorder →
- Attention Deficit Hyperactivity Disorder — all drugs for Attention Deficit Hyperactivity Disorder →
Sponsor
Tongji Hospital
Who can join
Adults 2 to 6, any sex, with Mental Retardation or Autism Spectrum Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to establish a new Chinese children's speech and language norm by obtaining the latest data of speech and language development of children aged 2 \~ 6 from different regions in China. At the same time, the overall development level and group differences of speech and language in Chinese children aged 2 to 6 years, and the influencing factors of speech and language development in Chinese children aged 2 to 6 years were also discussed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05442229
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Mental Retardation
Currently open trials in the same condition.
- NCT06934850 — The Relationship Between Hand Grip Strength, Trunk Control and Functional Performance in Individuals With Mild Mental Re · recruiting
- NCT07028333 — Effects of Different Dual-Task Exercises in Children With Mild Mental Retardation · NA · recruiting
- NCT06668519 — Magnetoencephalography in Children · recruiting
- NCT06657430 — A Study on the Preference of Risperidone Dosage Forms · recruiting
- NCT06848959 — Development and Application of a Diagnosis and Treatment System for Children's Brain Diseases Based on Knowledge Graphs · recruiting
Other Tongji Hospital trials
Trials by the same sponsor.
- NCT07537946 — Local Consolidation After Sintilimab Plus Lenvatinib for Metastatic Liver Cancer · Phase 3 · not yet recruiting
- NCT07537972 — Denosumab Strategy for Liver Cancer With Bone Metastases · Phase 2 · not yet recruiting
- NCT07537959 — Surgery Plus Systemic Therapy for Liver Cancer With Extrahepatic Metastases · NA · not yet recruiting
- NCT07527260 — Effects of Adenoidectomy on Symptoms and IgE Levels in Children With AR · NA · not yet recruiting
- NCT07524712 — Effects of Energy Versus Mechanical Surgical Devices on Postoperative Cough · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05442229 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tongji Hospital
- Last refreshed: 1 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05442229.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing